Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,739.60
(
-1.63%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,059.66
(
-3.90%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 160381

Friday, 04/26/2013 6:41:00 PM

Friday, April 26, 2013 6:41:00 PM

Post# of 257257
The Eliquis update in #msg-87309873 comes from yesterday's BMY CC. This is consequential info insofar as the Eliquis program in VTE prevention has been retarded in the US compared to the EU, where Eliquis received approval in 2011.

The AMPLIFY phase-3 study, which will determine whether BMY/PFE submit an sNDA for Eliquis in VTE treatment, is described in #msg-29928836.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now